NVCT logo

Nuvectis Pharma, Inc.

NVCT
Healthcare|Biotechnology|US
$20.91
+3.15 (+17.74%)
DCF Value
$1.18
Tangible Book / Share
$4.30
Cash / Share
$4.78
Next Earnings Report
Feb 10, 2027
EPS est. -$0.26
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Aug 21, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (3)

Dec 2026
Est. completion
P1EGFR Mutation Positive Non-small Cell Lung Cancer
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
NCT07315113n=18
Mar 2027
Est. completion
P1Advanced Solid Tumor
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
NCT05873686n=140
Aug 2027
Est. completion
P1ALK Positive
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
NCT07784959n=54

Recent Press Releases

Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
Nov 4, 2026 · GlobeNewsWire
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
Nov 2, 2026 · GlobeNewsWire
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
Oct 26, 2026 · GlobeNewsWire
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
Oct 9, 2026 · GlobeNewsWire
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
Sep 24, 2026 · GlobeNewsWire
Nuvectis Pharma To Participate in Upcoming Investor Conferences
Sep 3, 2026 · GlobeNewsWire

SEC Filings (40)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Aug 28, 2026EFFECTDocumentIndex
Aug 21, 2026S-3Shelf registrationDocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 4, 202610-QQuarterly reportDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jun 30, 20268-KMaterial eventDocumentIndex
Jun 30, 2026424B5Offering prospectusDocumentIndex
Jun 29, 2026424B5Offering prospectusDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 12, 20268-KMaterial eventDocumentIndex
May 5, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 27, 2026DEF 14AProxy / shareholder voteDocumentIndex
Feb 20, 2026EFFECTDocumentIndex
Feb 13, 2026S-3Shelf registrationDocumentIndex
Feb 11, 20268-KMaterial eventDocumentIndex
Feb 11, 202610-KAnnual reportDocumentIndex
Nov 4, 20258-KMaterial eventDocumentIndex
Nov 4, 202510-QQuarterly reportDocumentIndex
Sep 25, 20258-KMaterial eventDocumentIndex
Aug 5, 202510-QQuarterly reportDocumentIndex
Aug 5, 20258-KMaterial eventDocumentIndex
Jun 13, 20258-KMaterial eventDocumentIndex
May 9, 20258-KMaterial eventDocumentIndex
May 9, 2025424B5Offering prospectusDocumentIndex
May 6, 202510-QQuarterly reportDocumentIndex
May 6, 20258-KMaterial eventDocumentIndex
Apr 28, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 28, 2025DEF 14AProxy / shareholder voteDocumentIndex
Feb 25, 202510-KAnnual reportDocumentIndex
Feb 25, 20258-KMaterial eventDocumentIndex
Feb 6, 2025424B5Offering prospectusDocumentIndex
Feb 6, 20258-KMaterial eventDocumentIndex
Feb 4, 2025424B5Offering prospectusDocumentIndex
Jan 3, 2025S-8Employee stock planDocumentIndex